Author
Science for Life LaboratoryORCID 0000-0002-8697-4740Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
4 papers
Recent·Most cited
Wanda Christ, Bartłomiej Porębski, Óscar Fernández-Capetillo, Jonas Klingström
The paper identifies 70 antiviral compounds against Puumala Orthohantavirus through a drug repurposing screen in human cell lines.
bioRxiv · Mar 25, 2026 · PreprintCell Biology
Bartłomiej Porębski, Vanesa Lafarga, Catherine S. Hansel, Martin Haraldsson, Anabel Sáez-Mas, Ángela Sánchez-Molleda, Saioa Moragón, Maria Häggblad, Louise Lidemalm, Sara Rodrigo, Jordi Carreras Puigvert, Iván Ventoso, Miguel Lafarga, Daniela Hühn, Óscar Fernández-Capetillo
The paper identifies a chemical inducer of ribophagy, SALSa, that reduces toxicity of ALS-related arginine-rich peptides and extends lifespan in a Drosophila model.
bioRxiv · Mar 15, 2026 · PreprintMolecular Biology
Jan A. Schlegel, Bartłomiej Porębski, Luca Andronico, Leo Hanke, Steven J. Edwards, Hjalmar Brismar, Ben Murrell, Gerald M. McInerney, Óscar Fernández-Capetillo, Erdinç Sezgin
This paper introduces a high-throughput platform for identifying host binding factors and antiviral drug targets by overcoming limitations in host plasma membrane complexity.
Nano Letters · Mar 9, 2023Peer-reviewedSynthetic Biology
Valeria Colicchia, Maria Häggblad, Oleksandra Sirozh, Bartłomiej Porębski, Mirela Bălan, Louise Lidemalm, Jordi Carreras Puigvert, Daniela Hühn, Óscar Fernández-Capetillo
The paper identifies chemical and genetic regulators of the tetracycline-inducible gene expression system in mammalian cells, showing that FDA-approved drugs and genetic modifiers inhibit the system rather than alleviate TDP-43 toxicity.
bioRxiv · Mar 16, 2022 · PreprintMolecular Biology